VT News
Amos Otis

Amos Otis

Ask VT AI
View News Summary
  • FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
  • National Trust to cut 550 jobs, about 6% of workforce, due to budget pressures from tax increases.
  • Amid escalating diplomatic tensions, Russia and Poland engage in a tit-for-tat closure of consulates, underscoring the worsening relations between the two countries.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
  • National Trust to cut 550 jobs, about 6% of workforce, due to budget pressures from tax increases.
  • Amid escalating diplomatic tensions, Russia and Poland engage in a tit-for-tat closure of consulates, underscoring the worsening relations between the two countries.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Amos Otis

Top Topics

Trending in U.S.

World

Sport